Taiwan Journal of Ophthalmology (Jan 2022)

Intravitreal aflibercept combined with transpupillary thermotherapy in the treatment of refractory macular edema due to primary uveal melanoma

  • Yu-Te Huang,
  • Chun-Ju Lin,
  • Ning-Yi Hsia,
  • Chun-Ting Lai,
  • Henry Bair,
  • Yi-Yu Tsai

DOI
https://doi.org/10.4103/tjo.tjo_44_21
Journal volume & issue
Vol. 12, no. 4
pp. 482 – 486

Abstract

Read online

We reported a 74 year old Asian female with a uveal tumor with subretinal fluid (SRF) and cystoid macula edema. Since she declined biopsy, multimodal imaging study was performed, including fundus photography, ultrasonography, optical coherence tomography, fluorescein angiography, and magnetic resonance imaging. Uveal melanoma was diagnosed. However, despite aggressive treatment with TTT and three adjuvant intravitreal bevacizumab doses, SRF, and cystoid macula edema were persistent. Therefore, aflibercept was administered, resulting in anatomical and functional improvement within 1 month, which lasted for 12 months. Aflibercept offered great efficacy in improving refractory macular edema in this case of primary uveal melanoma. Multimodal imaging can provide us with more diagnostic clues in differentiating the nature of intraocular tumors.

Keywords